Concord Biotech Ltd vs Rpg Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Concord Biotech Ltd is ₹ 1165 as of 04 May 09:09 . The P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2024 to 47.2 on March 2025 . This represents a CAGR of -4.45% over 2 yearsThe P/E Ratio of RPG Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Concord Biotech Ltd changed from ₹ 15922 crore on March 2024 to ₹ 17537 crore on March 2025 . This represents a CAGR of 4.95% over 2 yearsThe Market Cap of RPG Life Sciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Concord Biotech Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 287.74 crore. This represent the decline of -100% The revenue of RPG Life Sciences Ltd for the Mar '26 is ₹ 190.39 crore as compare to the Dec '25 revenue of ₹ 183.44 crore. This represent the growth of 3.79% The ebitda of Concord Biotech Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 104.98 crore. This represent the decline of -100% The ebitda of RPG Life Sciences Ltd for the Mar '26 is ₹ 46.33 crore as compare to the Dec '25 ebitda of ₹ 34.75 crore. This represent the growth of 33.32% The net profit of Concord Biotech Ltd changed from ₹ 75.92 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of RPG Life Sciences Ltd changed from ₹ 34.93 crore to ₹ 29.9 crore over 8 quarters. This represents a CAGR of -7.48% The Dividend Payout of Concord Biotech Ltd changed from 2.73 % on March 2022 to 24.54 % on March 2025 . This represents a CAGR of 73.15% over 4 yearsThe Dividend Payout of RPG Life Sciences Ltd changed from 29.77 % on March 2021 to 21.66 % on March 2025 . This represents a CAGR of -6.16% over 5 years .

About Concord Biotech Ltd

Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

About RPG Life Sciences Ltd

RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

FAQs for the comparison of Concord Biotech Ltd and RPG Life Sciences Ltd

Which company has a larger market capitalization, Concord Biotech Ltd or RPG Life Sciences Ltd?

Market cap of Concord Biotech Ltd is 11,927 Cr while Market cap of RPG Life Sciences Ltd is 3,799 Cr

What are the key factors driving the stock performance of Concord Biotech Ltd and RPG Life Sciences Ltd?

The stock performance of Concord Biotech Ltd and RPG Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Concord Biotech Ltd and RPG Life Sciences Ltd?

As of May 4, 2026, the Concord Biotech Ltd stock price is INR ₹1140.15. On the other hand, RPG Life Sciences Ltd stock price is INR ₹2297.45.

How do dividend payouts of Concord Biotech Ltd and RPG Life Sciences Ltd compare?

To compare the dividend payouts of Concord Biotech Ltd and RPG Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.